These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 16356871

  • 1. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
    Sotiropoulos GC, Malago M, Molmenti EP, Radtke A, Brokalaki EI, Nadalin S, Lang H, Frilling A, Baba HA, Kühl H, Verhagen R, Broelsch CE.
    Eur J Med Res; 2005 Dec 07; 10(12):539-42. PubMed ID: 16356871
    [Abstract] [Full Text] [Related]

  • 2. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
    Wong LL, Tanaka K, Lau L, Komura S.
    Clin Transplant; 2004 Jun 07; 18(3):227-34. PubMed ID: 15142041
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL.
    Liver Transpl; 2005 Sep 07; 11(9):1117-26. PubMed ID: 16123960
    [Abstract] [Full Text] [Related]

  • 4. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH, Walser EM, Paz-Fumagalli R, McKinney JM, May GR.
    Cardiovasc Intervent Radiol; 2007 Sep 07; 30(5):888-93. PubMed ID: 17619218
    [Abstract] [Full Text] [Related]

  • 5. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, Guan SH, Shan H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov 07; 27(11):1749-51. PubMed ID: 18024306
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology.
    Sotiropoulos GC, Malagó M, Molmenti E, Paul A, Nadalin S, Brokalaki EI, Verhagen R, Dirsch O, Gerken G, Lang H, Broelsch CE.
    Hepatogastroenterology; 2005 Nov 07; 52(62):329-32. PubMed ID: 15816428
    [Abstract] [Full Text] [Related]

  • 7. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP.
    Liver Transpl; 2005 Dec 07; 11(12):1505-14. PubMed ID: 16315294
    [Abstract] [Full Text] [Related]

  • 8. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL, Furth EE, Olthoff K, Shaked A, Soulen MC.
    J Gastrointestin Liver Dis; 2009 Jun 07; 18(2):169-76. PubMed ID: 19565046
    [Abstract] [Full Text] [Related]

  • 9. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y.
    Radiol Med; 2002 Jun 07; 104(5-6):412-20. PubMed ID: 12589262
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, Lowell JA, Shenoy S, Darcy MD, Brown DB.
    Ann Surg; 2008 Oct 07; 248(4):617-25. PubMed ID: 18936575
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
    Fontana RJ, Hamidullah H, Nghiem H, Greenson JK, Hussain H, Marrero J, Rudich S, McClure LA, Arenas J.
    Liver Transpl; 2002 Dec 07; 8(12):1165-74. PubMed ID: 12474157
    [Abstract] [Full Text] [Related]

  • 12. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT, Devera MB, Marsh JW, Fontes P, Amesur NB, Holloway SE, Nalesnik M, Geller DA, Steel JL, Gamblin TC.
    Ann Surg Oncol; 2008 Nov 07; 15(11):3169-77. PubMed ID: 18696158
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Moreno Planas JM, López Monclús J, Gómez Cruz A, Rubio González E, Pérez Arangüena R, Boullosa Graña E, Garcia Suárez A, Pérez-Picouto JL, Fernández Ruiz M, Lucena de la Poza JL, Sánchez Turrión V, Cuervas-Mons Martínez V.
    Transplant Proc; 2005 Apr 07; 37(3):1484-5. PubMed ID: 15866648
    [Abstract] [Full Text] [Related]

  • 14. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB, Weissman J, Perkins JD.
    Clin Transplant; 2009 Apr 07; 23(6):874-81. PubMed ID: 19453644
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of superselective chemoembolization and radiofrequency ablation of hepatocellular carcinoma assessed in 21 explanted livers.
    Lang EK, Brammer M, Charafeddine R, Regenstein F, Haque S, Florman S, Cline K, Slakey D.
    J La State Med Soc; 2008 Apr 07; 160(5):258-62. PubMed ID: 19048980
    [Abstract] [Full Text] [Related]

  • 16. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G.
    Eur J Gastroenterol Hepatol; 2008 Mar 07; 20(3):196-201. PubMed ID: 18301300
    [Abstract] [Full Text] [Related]

  • 17. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer.
    Wang YH, Liu JF, Li F, Li A, Liu Q, Liu DB, Liu DG, Wang YJ.
    Chin Med J (Engl); 2009 Apr 20; 122(8):889-94. PubMed ID: 19493409
    [Abstract] [Full Text] [Related]

  • 18. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W.
    Liver Transpl; 2003 Jun 20; 9(6):557-63. PubMed ID: 12783395
    [Abstract] [Full Text] [Related]

  • 19. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma.
    Huang J, He X, Lin X, Zhang C, Li J.
    Chin Med J (Engl); 2000 May 20; 113(5):446-8. PubMed ID: 11776102
    [Abstract] [Full Text] [Related]

  • 20. Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.
    Nicolini A, Martinetti L, Crespi S, Maggioni M, Sangiovanni A.
    J Vasc Interv Radiol; 2010 Mar 20; 21(3):327-32. PubMed ID: 20097098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.